RxDoctor Payments Data

Jaime Sanchez, MD

Colon & Rectal Surgery · Tampa, FLNPI 1114126919

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (50.9%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 20 manufacturers reported payments, led by Medtronic at 34.9% of the total. Reporting peaked in 2022 at $39,892 and has fallen 91.4% since, to $3,444 in 2025. Among colon & rectal surgery clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$156,599in general payments, 2019–2025

Across 132 payments — averaging $1186.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$55K
  • Stryker$45K
  • Covidien LP$24K
  • Applied Medical Resources Corporation$18K
  • Intuitive Surgical$8K
  • Johnson & Johnson$6K
  • plus $2K from 14 others
$375,642in research payments, 2019–2025

Across 82 payments — averaging $4581.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Takeda Pharmaceuticals U.S.A., Inc.$376K

What the payments were for

  • Consulting fees$79,66051%
  • Speaking & faculty fees$56,75036%
  • Travel & lodging$12,3888%
  • Food & beverage$2,2651%
  • Education$5,5364%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$156,599 in reported general payments places this provider in the 90th percentile of 157 colon & rectal surgery providers in Florida.

See all colon & rectal surgery providers in Florida

Medicare billing

Part B allowed, 2024
$39,322
Medicare patients
74
Services billed
156

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Metronidazole11$15

Paid to pharmacies, not to this prescriber.

Other colon & rectal surgery in Tampa

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →